Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 and up Women only

Using antibiotics before bladder Botox injections

Official title: Use of Prophylactic Antibiotics Prior to OnabotulinumtoxinA Treatment of Overactive Bladder: a Randomized Controlled Trial

Run by Atlantic Health System · NCT05519072 · Data updated 2026-11-12

This study tests if skipping antibiotics before bladder Botox injections is just as safe as using them for people getting the procedure.

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment140 (estimated)
SponsorAtlantic Health System
Academic / other
Locations1 site (Morristown, New Jersey)
StatusRecruiting
StartedAugust 16, 2022
Main results expectedAugust 16, 2024
Study endsAugust 16, 2024
Registry record updatedMarch 27, 2024
Trial IDNCT05519072 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are females aged 18 and older who are scheduled to undergo bladder Botox treatment.

Probably not a fit

Patients who are pregnant, breastfeeding, or have contraindications to Botox or antibiotics will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates whether not using antibiotic prophylaxis before bladder Botox injections is as safe as using antibiotics. Participants will be randomly assigned to receive either antibiotics or no treatment prior to their Botox procedure. The study aims to reduce unnecessary antibiotic use, addressing the issue of antibiotic resistance, while monitoring for urinary tract infections and other related complications. Follow-up assessments will occur two weeks and six weeks post-treatment to evaluate outcomes.

Why it matters

Potential benefit: If successful, this study could lead to reduced antibiotic use in bladder Botox procedures, minimizing the risk of antibiotic resistance.

How similar studies have gone: Other studies have explored antibiotic use in similar contexts, but this specific approach to bladder Botox procedures is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Female
* Age ≥ 18
* Patient undergoing bladder Botox treatment

Exclusion Criteria:

* Pregnant and/or breastfeeding
* Contraindication to injection of Botox - hypersensitivity to any botulinum toxin preparation or to any of the components in the formulation, symptomatic urinary retention or post void residual (PVR) \> 200 mL, unwillingness or inability to initiate clean intermittent catheterization (CIC) post-treatment if required.
* Contraindication to oral antibiotics - hypersensitivity or allergy
* Inability to take medication by mouth

Where it's running

  • Atlantic Health
    Morristown, New Jersey, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.